Regulatory Rapporteur January 2006

<< back to list of Issues

Front Cover
Volume 3 Issue 1

In This Issue

  • Focus on immunotoxicity guidelines
  • Assessing carcinogenicity in the absence of standard rodent carcinogenicity data
  • The value of regulatory information in clinical research
  • 10 years of EMEA CNS medicines - Anti-dementia treatments

Please login to view member only articles. Non-members may download the public articles.

TitleDownloadCategorySizeFile
Regulatory Rapporteur January 2006MembersFull Issue2MBPDF
An overview of immunotoxicity guidelines - past to presentPublic154KBPDF
10 Years of EMEA CNS medicines - 3 Anti-dementia treatmentsMembers149KBPDF
Assessing carcinogenicity in the absence of standard rodent carcinogenicity dataMembers128KBPDF
CRED workshop: Mastering the practical aspects of the SmPC, PIL and labellingMembers228KBPDF
EU Regulatory Intelligence: Updates November 2005 - January 2006Members211KBPDF
Maple Leaf News - Update from CanadaMembers166KBPDF
Medical technologies regulation in South AmericaMembers104KBPDF
The Exchange: Co-ordinated by Origin Pharmaceutical Services LimitedMembers296KBPDF
The value of regulatory information in clinical researchMembers227KBPDF
Welcome to the first 2006 issue of Regulatory RapporteurMembers100KBPDF